Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wagner

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Breast Care (Basel, Switzerland)|September 30, 2010
Breast Centers in GermanyUte-Susann Albert, Uwe Wagner, Matthias Kalder
Molecular and Cellular Endocrinology|April 9, 2013
D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cellsQian Zhang, Kazuhito Sakamoto, Kay-Uwe Wagner
Future Oncology (London, England)|October 4, 2012
The changing landscape of therapeutic strategies for recurrent ovarian cancerKlaus H Baumann, Uwe Wagner, Andreas du Bois
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Mouse models of breast cancerKazuhito Sakamoto, Jeffrey W Schmidt, Kay-Uwe Wagner
Breast Cancer Research and Treatment|July 30, 2023
Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022Niklas Gremke, Uwe Wagner, Matthias Kalder, et al.
Cancer Research|March 28, 2014
Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapiesWan-Chi Lin, Nirakar Rajbhandari, Kay-Uwe Wagner
Neoplasia (New York, N.Y.)|December 3, 2008
A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesisAleata A Triplett, Cristina Montagna, Kay-Uwe Wagner
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cellsSilke Reinartz, Sophie Failer, Tina Schuell, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Use Case Evaluation and Digital Workflow of Breast Cancer Care by Artificial Intelligence and Blockchain Technology ApplicationSebastian Griewing, Michael Lingenfelder, Uwe Wagner, et al.
Plos One|September 7, 2012
Generation of a novel MMTV-tTA transgenic mouse strain for the targeted expression of genes in the embryonic and postnatal mammary glandKazuhito Sakamoto, Jeffrey W Schmidt, Kay-Uwe Wagner
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Breast Care (Basel, Switzerland)|September 30, 2010
Breast Centers in GermanyUte-Susann Albert, Uwe Wagner, Matthias Kalder
Molecular and Cellular Endocrinology|April 9, 2013
D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cellsQian Zhang, Kazuhito Sakamoto, Kay-Uwe Wagner
Future Oncology (London, England)|October 4, 2012
The changing landscape of therapeutic strategies for recurrent ovarian cancerKlaus H Baumann, Uwe Wagner, Andreas du Bois
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Mouse models of breast cancerKazuhito Sakamoto, Jeffrey W Schmidt, Kay-Uwe Wagner
Breast Cancer Research and Treatment|July 30, 2023
Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022Niklas Gremke, Uwe Wagner, Matthias Kalder, et al.
Cancer Research|March 28, 2014
Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapiesWan-Chi Lin, Nirakar Rajbhandari, Kay-Uwe Wagner
Neoplasia (New York, N.Y.)|December 3, 2008
A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesisAleata A Triplett, Cristina Montagna, Kay-Uwe Wagner
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cellsSilke Reinartz, Sophie Failer, Tina Schuell, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Use Case Evaluation and Digital Workflow of Breast Cancer Care by Artificial Intelligence and Blockchain Technology ApplicationSebastian Griewing, Michael Lingenfelder, Uwe Wagner, et al.
Plos One|September 7, 2012
Generation of a novel MMTV-tTA transgenic mouse strain for the targeted expression of genes in the embryonic and postnatal mammary glandKazuhito Sakamoto, Jeffrey W Schmidt, Kay-Uwe Wagner
Pageof 22